| 查看: 173 | 回复: 0 | ||
shiyu09木虫 (正式写手)
|
[求助]
求一篇文献
|
|
求文献： Sample size determination for bioequivalence assessment by means of confidence intervals. Diletti E, Hauschke D, Steinijans VW. SourceDepartment of Biometry, Byk Gulden Pharmaceuticals, Konstanz, Germany. Abstract The statistical analysis of bioequivalence assessment has been consolidated in recent years through the work of Schuirmann [1987], Westlake [1988] and Hauschke et al. [1990], and this has been reflected in the CPMP Note for Guidance on Bioavailability and Bioequivalence and in the joint recommendations of the APV (International Association for Pharmaceutical Technology) and ZL (Central Laboratories of German Pharmacists) during a recent workshop in support of EC-Guidelines [Blume et al. 1990]. Since the decision procedure based on the inclusion of the shortest 90%-confidence interval in the bioequivalence range is the procedure of choice, and as this is equivalent to the two one-sided tests procedure, the sample size determination is based on the power of the latter. Following the approach of Phillips [1990] for the additive model, corresponding nomograms for the more relevant multiplicative model are given in this paper for various ratios of the expected means for test and reference and various coefficients of variation. 个人邮箱：pushiyu09@163.com |
回复此楼» 猜你喜欢
323分（计算机视觉和大模型项目）能直接上手
已经有3人回复
-
复试调剂
已经有3人回复
-
311分 22408 求调剂
已经有3人回复
-
320分人工智能调剂
已经有7人回复
-
一志愿郑大0705求调剂
已经有4人回复
-
0703化学
已经有10人回复
-
301求调剂
已经有10人回复
-
306分材料与化工求调剂
已经有6人回复
-
材料调剂
已经有11人回复
-
324求调剂
已经有9人回复
